Sometimes stories that seek to go deeper than what the immediate headlines and the most obvious angles offer are richly rewarded by audience attention. And most-read story of this week falls in that category where it pulls back the curtain from a failed cancer trial to reveal the hype that surrounds the novel cancer immunotherapy.
Other popular stories were an analysis of Apple’s recent purchase of a personal health record company and looking at diabetes in a new way.
With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
What no one is telling you about BMS’ Opdivo immunotherapy trial failure
Apple said to acquire PHR vendor Gliimpse; should anyone care?
Watch out, EpiPen: A better auto-injector for severe allergies is in the works
Iodine completes first mental health integration of Apple CareKit-developed app
Image: Getty Images, Meriel Jane Waissman